Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea
· Delayed Price · Currency is KRW
46,200
-1,300 (-2.74%)
Last updated: Jun 26, 2025
Next Biomedical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '25 Jun 25, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 365,306 | 331,554 | - | - | - | - | |
| Last Close Price | 44950.00 | 41000.00 | - | - | - | - | |
| PE Ratio | 130.75 | 115.95 | - | - | - | - | |
| PS Ratio | 33.38 | 34.74 | - | - | - | - | |
| PB Ratio | 8.06 | 7.34 | - | - | - | - | |
| P/TBV Ratio | 8.12 | 7.39 | - | - | - | - | |
| Debt / Equity Ratio | 0.24 | 0.24 | 0.70 | 0.56 | 6.25 | -0.37 | |
| Asset Turnover | 0.25 | 0.22 | 0.16 | 0.08 | 0.07 | 0.09 | |
| Inventory Turnover | 1.62 | 1.60 | 1.37 | 1.61 | 1.83 | 1.23 | |
| Quick Ratio | 3.60 | 3.68 | 1.35 | 1.38 | 1.70 | 0.18 | |
| Current Ratio | 3.85 | 3.95 | 1.57 | 1.59 | 1.82 | 0.24 | |
| Return on Equity (ROE) | 9.02% | 9.28% | -41.64% | -46.30% | - | - | |
| Return on Assets (ROA) | -5.17% | -5.05% | -10.57% | -10.03% | -13.55% | -12.52% | |
| Return on Capital (ROIC) | -5.46% | -5.31% | -11.14% | -10.68% | -64.38% | -4371.23% | |
| Earnings Yield | 0.76% | 0.86% | - | - | - | - | |
| FCF Yield | -0.26% | -0.50% | - | - | - | - | |
| Buyback Yield / Dilution | -24.75% | -17.78% | -1.10% | -28.34% | -13.05% | -199.99% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.